Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Verena Kaegi"'
Autor:
Daniel Bur, Azely Mirre, Michel Enderlin-Paput, Georg Rueedi, Christian Hubschwerlen, Hans H. Locher, Daniel Ritz, Cornelia Zumbrunn, Wolfgang Keck, Maria Boehme, Marina Dos Santos, Jean-Christophe Gauvin, Peter Seiler, Jean-Philippe Surivet, Verena Kaegi, Jonathan Delers, Christopher Kohl, Thierry Bruyère, Mika Gaertner
Publikováno v:
Journal of Medicinal Chemistry. 56:7396-7415
There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed8ae2c35d8e3bcbd6ebfe5d79033c9
https://doi.org/10.1021/jm400963y
https://doi.org/10.1021/jm400963y
Autor:
Marina Dos Santos, Daniel Ritz, Verena Kaegi, Azely Mirre, Maria Weiss, Stéphanie Kraemer, Daniel Bur, Michel Enderlin-Paput, Jean-Christophe Gauvin, Hakim Hadana, Georg Rueedi, Thierry Bruyère, Christian Hubschwerlen, Peter Seiler, Mika Gaertner, Jonathan Delers, Christopher Kohl, Wolfgang Keck, Jean-Philippe Surivet, Hans H. Locher, Patrick Hess, Eric A. Ertel, Cornelia Zumbrunn, Romain Sube
Publikováno v:
Journal of medicinal chemistry. 58(2)
Novel antibacterial drugs that are effective against infections caused by multidrug resistant pathogens are urgently needed. In a previous report, we have shown that tetrahydropyran-based inhibitors of bacterial type II topoisomerases (DNA gyrase and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e943cd2f129c2bf098a7a5867bb79e41
https://pubmed.ncbi.nlm.nih.gov/25494934
https://pubmed.ncbi.nlm.nih.gov/25494934